Download presentation
1
Autonomic Pharmacology 张纬萍 浙江大学医学院药理 weiping601@zju.edu.cn
2
第一次课的内容 1、传出神经系统简介 2、胆碱能神经系统 (1)胆碱受体激动药 (2)胆碱酯酶抑制药
3
Nervous System 神经系统
4
Nervous System Peripheral Nervous System (PNS) Central System (CNS) 神经系统
5
Nervous System Peripheral Nervous System (PNS) Central System (CNS) Efferent Division Afferent 神经系统
6
Nervous System Peripheral Nervous System (PNS) Central System (CNS) Efferent Division Afferent Somatic motor 神经系统
7
Nervous System Peripheral Nervous System (PNS) Central Nervous System (CNS) Efferent Division Afferent Division Autonomic nervous System (ANS) Somatic motor Nervous System 神经系统
8
Sympathetic 交感 Nervous System Peripheral Nervous System (PNS) Central System (CNS) Efferent Division Afferent Parasympathetic副交感 Enteric 肠神经系统 Autonomic nervous System (ANS) Somatic motor Nervous System 神经系统
9
交感和副交感神经系统
10
thoracolumbar craniosacral
11
The Enteric Nervous System肠神经系统 (+SNS/PSNS)
longitudinal muscle layer 纵行肌 Myenteric plexus 肌间神经丛 Circular muscle layer 环行肌 Submucosal plexus 粘膜下神经丛 Secretory cell 分泌细胞 Enterochromaffin cell 肠噬铬细胞 Absorptive cell 吸收细胞 The Enteric Nervous System肠神经系统 (+SNS/PSNS)
13
The release of noradrenaline has the following effects
stimulates heartbeat raises blood pressure dilates the pupils dilates the trachea and bronchi stimulates the conversion of liver glycogen into glucose shunts blood away from the skin and viscera to the skeletal muscles, brain, and heart inhibits peristalsis in the gastrointestinal (GI) tract inhibits contraction of the bladder and rectum
14
Parasympathetic stimulation causes
slowing down of the heartbeat lowering of blood pressure constriction of the pupils increased blood flow to the skin and viscera peristalsis of the GI tract
15
Peripheral Nervous System (PNS) Central System (CNS)
Sympathetic Nervous System Peripheral Nervous System (PNS) Central System (CNS) Efferent Division Afferent Parasympathetic (Enteric) Drugs that produce their primary therapeutic effect by mimicking or altering the functions of autonomic nervous system are called autonomic drugs. Autonomic nervous System (ANS) Somatic motor Nervous System 神经系统
16
Neurotransmitters Receptors
drugs Neurotransmitters Synthesis Storage Release Inactivation Receptors Activation
17
Neurotransmitters Receptors
Indirect actions Mimetics Synthesis Transport and storage Release Inactivation Direct-acting: receptor agonists Indirect-acting: increasing amounts and/or effects of transmitters drugs Direct actions Antagonists Agonists激动剂 Direct-acting: receptor antagonists Indirect-acting: decreasing amounts and/or effects of transmitters Antagonists 拮抗剂 Receptors
18
Neurotransmitters Receptors
Indirect actions Mimetics Synthesis Transport and storage Release Inactivation Direct-acting: receptor agonists Indirect-acting: increasing amounts and/or effects of transmitters drugs Direct actions Antagonists Agonists激动剂 Direct-acting: receptor antagonists Indirect-acting: decreasing amounts and/or effects of transmitters Antagonists 拮抗剂 Receptors
19
Cholinergic Pharmacology
Adrenergic Pharmacology
20
Cholinergic Terminal Choline Uptake ACh Synthesis ACh Storage
Choline acetyltransferase(ChAT) Choline + AcCoA → ACh ChAT ACh Storage ACh Release ACh Effects Postsynaptic Presynaptic ACh Metabolism Acetylcholinesterase(AChE) ACh → Choline + Acetate AChE
21
Acetylcholine Release
by exocytosis Regulation - by auto-receptors ACh acting on presynaptic M2-cholinergic receptors - by hetero-receptors NE acting on presynaptic a2-adrenergic receptors - by metabolism (extra-neuronal)
22
Cholinesterases 胆碱酯酶 Acetylcholinesterase is located at cholinergic synapses and in erythrocytes (does not hydrolyze succinylcholine) Pseudocholinesterase (假性胆碱酯酶,synonyms: plasma cholinesterase or butyrylcholinesterase丁酰胆碱酯酶) exists mainly in plasma, liver and in glia (hydrolyzes succinylcholine) AChE主要存在于突触间隙、胆碱能神经元、红细胞,水解ACh BChE主要存在于血浆,水解其他胆碱脂类
23
Cholinergic Receptors
(cholinoceptors, acetylcholine receptors) Muscarinic receptors (M receptors) M1, 3, 5 ; M2, 4 G-protein Coupled End Organs Nicotinic receptors (N receptors) NN (N1) receptors; NM(N2 ) receptors Ligand-gated Ion Channels NMJ & Ganglia
24
M receptors : G-protein Coupled
Smooth Muscle contraction cAMP↓ Heart rate↓ M receptors : G-protein Coupled Muscarinic Receptor Signaling Pathways (first, second, third messenger)
25
M receptors : end organs and effect of activation
血管平滑肌:收缩或舒张 The response of an isolated blood vessel to ACh depends on whether the endothelium is intact (unrubbed) or missing When the endothelium is present, ACh causes smooth muscle relaxation by stimulating the production of nitric oxide (NO) in the endothelium In the absence of the endothelium, a small amount of vasoconstriction is observed ——Fred Murad, 1998
26
M receptors : end organs and effect of activation
心脏:Depression of the heart — 负性肌力:NE释放 — 负性频率:open K+ channel,depolarization — 负性传导:AV node and Purkinje fibers — 缩短心房不应期: AP duration
27
M receptors : end organs and effect of activation
平滑肌:收缩(sensitive: GI tract, bronchial, urinary bladder; insensitive: uterine, blood vascular) Mostly smooth muscle contraction - heart being the main exception 外分泌腺:sensitive: sweat, tears, salivary; insensitive: GI tract; Eye (contraction of sphincter muscle of iris: miosis缩瞳; contraction of ciliary muscle睫状肌 收缩: contraction for near vision) CNS: activation,yet ACh can hardly pass BBB
28
N receptors : subtypes and location
NN receptors( N1 receptors ) Sympathetic and parasympathetic ganglia Adrenal medulla NM receptors (N2 receptors ) The Neuromuscular Junction (NMJ) (Contraction of skeletal muscles)
29
Ligand-gated Ion Channels
N receptors : Ligand-gated Ion Channels At the NMJ, N receptors Pentameric with four types of subunits, two a subunits bind ACh for ligand gating All other nAChRs, including those at the peripheral ganglia, have 2 a’s and 3 b’s
30
The Neuromuscular Junction (NMJ)
B The Neuromuscular Junction (NMJ)
31
Myasthenia Gravis重症肌无力
This means “serious disorder the NMJ” This is an autoimmune disease Antibodies against the a subunit of the nAChR The ability of ACh to activate the nAChRs is blocked by the antibodies As for many autoimmune diseases, stress can make the symptoms worse Treatment is to potentiate cholinergic signaling and to remove the antibodies (blood dialysis)
32
Drug classification ACh M- and N- Receptors drugs
Indirect actions Cholinesterase inhibitors (Anticholinesterases) Reversible: neostigmine 新斯的明 Irreversible: organophosphates drugs Direct actions Cholinoceptor agonists M, N receptor agonists: acetylcholine,乙酰胆碱 M receptor agonists: pilocarpine,匹鲁卡品 N receptor agonists: nicotine,尼古丁 Cholinergic antagonists M- and N- Receptors
33
Cholinomimetics: Direct-acting drugs
ACh Derivatives Bond cleaved by AChE 卡巴胆碱 乙酰胆碱 Poor perfusion of visceral organs and rapid hydrolysis by plasma butyrylcholinesterase limit access of systemically administered ACh to visceral muscarinic receptors. Parasympathetic sacral innervation causes detrusor muscle contraction, increased voiding pressure, and ureter peristalsis, but for similar reasons these responses are not evident with administered ACh. 氯贝胆碱 AChE Resistant 乙酰甲胆碱
34
Cholinomimetics: Direct-acting drugs
Bethanechol is most commonly used, particularly post-operation for the treatment of paralytic ileus(麻痹性肠梗阻) and urinary retention(尿储留)
35
Natural Muscarinic Agonists
匹鲁卡品 毛果云香硷 毒蕈碱 槟榔碱 areca or betal nuts (India,E. Indies) pilocarpus (S. Amer. shrub) amanita muscaria (mushroom) (Most to least nicotinic)
36
“Food” Poisoning Amanita muscaria => muscarine
Atropa belladonna => atropine Deadly Nightshade, 癫茄 Pilocarpus=> Pilocarpine Areca nuts=> Arecoline
37
“Food” Poisoning Poisoning causes muscarinic overstimulation or blocking (for belladonna only) - salivation, lacrimation(流泪), visual disturbances; - abdominal colic and diarrhea - bronchospasm and bradycardia - hypotension; shock Treatment is with atropine
38
Muscarinic Agonists: Parasympathetic Effects & Therapeutic Uses
Pilocarpine (1)Eyes Miosis(缩瞳): contraction of sphincter muscle of iris Lowing intraocular pressure: enlarging angle of anterior chamber, increasing drainage of aqueous humor Spasm of accommodation(调节痉挛): contraction of ciliary muscle, contraction for near vision Ophthalmological uses Glaucoma(青光眼): (concentration ≤ 2%) narrow (closed)- or wide (open)-angles it is the drug of choice in the emergency lowering of intraocular pressure Iritis (虹膜炎): miotics(缩瞳)/mydriatics(扩瞳)
39
light 巩膜窦 小梁网 睫状体上皮细胞 睫状肌
40
atropine pilocarpine 悬韧带 lens miosis mydriasis paralysis of
accommodation near sight spasm of far sight iris Anterior chamber Ciliary muscle (contraction) zonule Canal of Schlemm posterior (dilation) 悬韧带
41
Glaucoma Disease of the aging eye - increased intraocular pressure (IOP), degeneration of the optic head, and restricted visual field typify primary open-angle glaucoma obstruction of the aqueous drainage leads to elevated IOP, and may result in glaucomatous damage to the optic nerve
42
Medical Conditions of the Eye
Cataracts - Clouding of the lens Glaucoma - Loss of peripheral or “side” vision
43
Medical Conditions of the Eye
Macular Degeneration - Loss of central or “straight ahead” vision Diabetic Retinopathy - Blurring of central vision to blindness
44
Glaucoma Glaucoma management involves lowering IOP by
- Decreasing aqueous production by the ciliary body - Increasing aqueous outflow through the trabecular meshwork (小梁网) and uveal outflow paths(房水排出通道) - Neuroprotection
45
Pilocarpine Increase Aqueous Humor Outflow
pilocarpine: parasympathomimetics increase aqueous outflow by contraction of the ciliary muscle to increase tone and alignment of the trabecular network
46
Muscarinic Agents: Parasympathetic Effects & Therapeutic Uses
Pilocarpine (2) Promoting secretion of exocrine glands, especially in sweat, salivary and tear glands (3) Gastrointestinal tract: increasing tone and motility (4) Urinary tract: contraction of bladder and relax for external sphincter muscles (5) Respiratory system: bronchoconstriction and secretion (5) CNS: cortical arousal or activation
47
Muscarinic Agents: Parasympathetic Effects & Therapeutic Uses
Other use (1) Gastrointestinal disorders, like gastroparesis (2) Urinary bladder disorders, urinary retention (3) Xerostomia(口腔干燥), (4) Antidote for atropine poisoning
48
N receptor agonists: Nicotine
- actions at ganglia, NMJ, brain Actions are complex and frequently unpredictable, because of the variety of neuroeffector sites and because nicotine both stimulates and desensitizes effectors. Nicotine typically will affect the: Periphery: HR, BP, GI tone & motility and also CNS: stimulation, tremors, respiration, emetic effects The addictive power of cigarettes is directly related to their nicotine content. 可用于戒烟
49
Drug classification 1 Cholinomimetics(Parasympathomimetics)
(1) Direct-acting drugs: Cholinoceptor agonists M, N receptor agonists: acetylcholine M receptor agonists: pilocarpine N receptor agonists: nicotine (2) Indirect-acting drugs: Cholinesterase inhibitors (Anticholinesterases) Reversible: neostigmine Irreversible: organophosphates
50
Drug classification 1 Cholinomimetics
(1) Direct-acting drugs: Cholinoceptor agonists M, N receptor agonists: acetylcholine M receptor agonists: pilocarpine N receptor agonists: nicotine (2) Indirect-acting drugs: Cholinesterase inhibitors (Anticholinesterases) Reversible: neostigmine Irreversible: organophosphates Cholinergic antagonists: Cholinesterase reactivators pralidoxime iodide
51
Cholinomimetics- Indirect Agents:
AChE Inhibitors
52
Acetylcholinesterase (AChE) Activity
酯解部位 阴离子部位 水解 Ach季胺阳离子头与阴离子部位结合 羰基碳与酯解部位的Ser结合 酯键断裂 乙酰化AChE 胆碱
53
These agents are reversible and are used medically (glaucoma or MG)
Cholinomimetics- Indirect Agents: AChE Inhibitors A. Edrophonium依酚氯铵 (reversible, competitive) B. Carbamates 氨甲酰类(slowly reversible) C. Organophosphates 有机磷类(irreversible) 新斯的明 依酚氯铵 异氟磷 依酚氯铵主要是非共价结合,还有他克林(tacrine)、多奈派齐(donepezil),后两者对AChE的亲和力高,脂溶性强,易进入中枢 氨甲酰酚羟基 neostigmine These agents are irreversible and are used as pesticides or for glaucoma These agents are reversible and are used medically (glaucoma or MG) 毒扁豆碱
54
Acetylcholinesterase Inhibitors: Reversible
Edrophonium 依酚氯铵 Rapidly absorbed; A short duration of action (5-15min); Competitive (reversible) Used in diagnosis of myasthenia gravis. Excess drug may provoke a cholinergic crisis, Atropine is the antidote. 或者判断治疗过程中抗AChE的药量是否不足OR过量;
55
Acetylcholinesterase Inhibitors: Carbamates
Inhibitory Effects are slowly reversible Representative Drugs neostigmine 新斯的明 (quaternary amine) physiostigmine 毒扁豆碱 (tertiary amine) pyridostigmine吡斯的明 quaternary amines effective in periphery only tertiary amines effective in periphery and CNS (fat-soluble) 二甲氨基甲酰化AChE
56
Acetylcholinesterase Inhibitors: Carbamates
neostigmine (quaternary amine) Pharmacological effects AChE(-), Ach ↑, directly stimulating NMR stronger effect on skeletal muscles effective on GI tract and urinary bladder more polar and can not enter CNS relatively ineffective on CVS, glands, eye
57
Acetylcholinesterase Inhibitors: Carbamates
neostigmine (quaternary amine) Clinical uses Myasthenia gravis: symptomatic treatment, overdose: cholinergic crisis Paralytic ileus and bladder: post operative abdominal distension and urinary retention Paroxysmal superventricular tachycardia(阵发性室上速) Antidote for tubocurarine (筒箭毒碱) and related drug poisoning
58
Acetylcholinesterase Inhibitors: Carbamates
neostigmine (quaternary amine) Adverse effects Cholinergic effects: muscarinic and nicotinic effects, treated with atropine (muscarinic) Contraindications: mechanical ileus 机械性肠梗阻 urinary obstruction 泌尿道梗阻 bronchial asthma 支气管哮喘 poisoning of depolarizing skeletal muscle relaxants (e.g. succinylcholine琥珀胆碱)
59
Other reversible AChE inhibitors
Pyridostigmine吡斯的明 Similar as neostigmine, slow but longer duration Physostigmine毒扁豆碱 Stronger than neostigmine No direct action on M and N receptor Can enter CNS, 先兴奋后抑制 Stimulate N receptor of sympathetic nervous node complex effects on cardiovascular system Stimulate N receptor of skeletal muscle 肌束震颤 主要用于急性青光眼,抗胆碱药中毒,但其本身的毒性较大。
60
Other reversible AChE inhibitors
Galanthamine加兰他敏 Similar as neostigmine, can enter CNS and treat for AD Dihydrogalanthamine二氢加兰他敏 Ambenonium chloride安贝氯胺 Demecarium bromide地美溴铵 Distigmine bomide溴地斯的明 Eseridine依舍立定 Eptastigmine依斯的明
61
Acetylcholinesterase Inhibitors: Irreversible
Bond is hydrolyzed in binding to the enzyme 对硫磷 马拉硫磷 乙膦硫胆碱 梭曼 For ophthalmic use These agents are used as pesticides or for glaucoma.
62
Acetylcholinesterase Inhibitors: Organophosphates
Effects of Organophosphates are irreversible (covalent bond formation) 异氟磷 老化 单烷氧基磷酰化AChE Pralidoxime(碘解磷定) can restore AChE activity if administered soon after toxin exposure. Conjugating with organophosphate by oxime group; Conjugating with free organophasphates 解磷定
63
Acetylcholinesterase Inhibitors: Organophosphates
(1) Toxic symptoms Acute intoxication Muscarinic symptoms eye, exocrine glands, respiration, GI tract, urinary tract, CVS Nicotinic symptoms NN: elevation of BP, increase of HR; N2: tremor of skeletal muscles CNS symptoms excitation, convulsion(抽搐); depression (advanced phase) Chronic intoxication usually occupational poisoning plasma ChE activity ↓,神经衰弱症候群 weakness, restlessness, anxiety, tremor, miosis, ……
64
Acetylcholinesterase Inhibitors: Organophosphates
(2) Detoxication Elimination of poison; Supportive therapy Antidotes Atropine-antagonizing muscarinic effects; early, larger dose, and repeated use Cholinesterase reactivators-reactivation of phosphated AChE; moderate-severe patients, early use (More effective on tremor), combined with atropine Pyraloxime chloride (氯解磷定):saver than PAM Pralidoxime iodide (PAM) (碘解磷定) Obidoxime chloride(双复磷): two active oxime groups 碘解磷定:最早的AChE复活药,但不稳定,对内吸磷、马拉硫磷和对硫磷有些,对敌百虫、敌敌畏等较差,对乐果无效; 双复磷:有两个污基,作用较强,较持久,易进入BBB,对M、N、CNS症状均有效
65
ACHEI Applications Pharmacological Actions: Increases ACh concentrations at cholinergic synapses, thereby increasing cholinergic activity. glaucoma (e.g. physiostigmine毒扁豆碱) myasthenia gravis (e.g. Edrophonium依酚氯胺, neostigmine新斯的明, pyridostigmine 吡斯的明) reverse neuromuscular blockade from competitive antagonists (neostigmine) Alzheimer’s disease (tacrine他克林 & donepezil多奈派齐) chemical warfare agents insecticides
66
Summary Cholinomimetics (Parasympathomimetics)
(1) Direct-acting drugs: Cholinoceptor agonists M, N receptor agonists: acetylcholine M receptor agonists: pilocarpine N receptor agonists: nicotine (2) Indirect-acting drugs: AChE inhibitors Reversible: neostigmine Irreversible: organophosphates Cholinesterase reactivators:PAM
67
See you next Class!
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.